AC Immune(ACIU)
1015 LAUSANNE, Switzerland
BiotechnologyFocus: Alzheimer's Treatments
AC Immune is a life sciences company focused on Alzheimer's Treatments.
Neurology
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
Optimization of Morphomer-based Alpha-synuclein PET Tracers
Parkinson DiseaseClinical Trials (1)
NCT05067192Optimization of Morphomer-based Alpha-synuclein PET Tracers
N/AACI-24 low dose
Down SyndromeClinical Trials (1)
NCT02738450Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome
Phase 1[18F]ACI-19626
Frontotemporal Dementia (FTD)Clinical Trials (1)
NCT06891716[18F]ACI-19626 PET in TDP-43 Proteinopathies
Phase 1[18F]MNI-1216
Alpha-SynucleinopathyClinical Trials (1)
NCT06445465Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain
Phase 1[18F]ACI-15916
Parkinson's Disease (PD)Clinical Trials (1)
NCT06891703[18F]ACI-15916 PET in α-synucleinopathies
Phase 1Placebo
Amyloid PlaqueClinical Trials (1)
NCT05462106A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
Phase 1/2ACI-35.030
Alzheimer's DiseasePlacebo
Parkinson DiseaseClinical Trials (1)
NCT06015841A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease
Phase 2ACI-24
Down SyndromeClinical Trials (1)
NCT04373616A Study of ACI-24 in Adults With Down Syndrome
Phase 2Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 8 clinical trials
Open Roles: 1 active job